abstract |
The present invention provides a somatostatin receptor subtype 2 agonist. Since the compound represented by the general formula (I), the salt thereof, the N-oxide or the solvate thereof, or the prodrug thereof disclosed in the present invention is a low molecular compound having a strong somatostatin receptor subtype 2 working activity It is useful for the prevention and / or treatment of somatostatin-related diseases such as acromegaly and gastrointestinal obstruction because it can be administered by a simple method, has high stability and low toxicity. (I) Wherein all symbols have the same meanings as defined in the description. |